Health Insurance and Utilization in Pneumocystis Carinii Pneumonia

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 1995 Aug 1

PMID 7472705

Authors

S Loue

D J Slymen

H Morgenstern

C Whalen

Affiliations

Soon will be listed here.

Abstract

To examine the relationship between health insurance status and health services utilization among HIV-infected patients with active Pneumocystis carinii pneumonia (PCP), the discharge and outpatient databases of a large California medical facility were reviewed. Four hundred fifty records met the inclusion criteria. Logistic regression indicated that those who had publicly funded insurance were about half as likely (95% CI 0.28, 0.99) as were those who had private insurance to undergo bronchoscopy with bronchoalveolar lavage at the time of their first PCP episodes. Further research is required to identify the reasons for this difference.

References

HOWELL E . Low-income persons' access to health care: NMCUES Medicaid data. Public Health Rep. 1988; 103(5):507-14. PMC: 1478122. View

Sackett D . Bias in analytic research. J Chronic Dis. 1979; 32(1-2):51-63. DOI: 10.1016/0021-9681(79)90012-2. View

. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus.... J Acquir Immune Defic Syndr (1988). 1993; 6(1):46-55. View

Stover D, White D, Romano P, Gellene R, Robeson W . Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985; 78(3):429-37. DOI: 10.1016/0002-9343(85)90334-1. View

Turner B, Markson L, McKee L, Houchens R, Fanning T . The AIDS-defining diagnosis and subsequent complications: a survival-based severity index. J Acquir Immune Defic Syndr (1988). 1991; 4(10):1059-71. View

Murray J, Felton C, Garay S, Gottlieb M, Hopewell P, Stover D . Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med. 1984; 310(25):1682-8. DOI: 10.1056/NEJM198406213102529. View

Brenner M, Ognibene F, Lack E, Simmons J, Suffredini A, Lane H . Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1987; 136(5):1199-206. DOI: 10.1164/ajrccm/136.5.1199. View

Ellwood M, Fanning T, Dodds S . Medicaid eligibility patterns for persons with AIDS in California and New York, 1982-1987. J Acquir Immune Defic Syndr (1988). 1991; 4(10):1036-45. View

Solomon L, Frank R, Vlahov D, Astemborski J . Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health. 1991; 81(10):1285-90. PMC: 1405342. DOI: 10.2105/ajph.81.10.1285. View

10.

Bing E, Soto T . Treatment issues for African-Americans and Hispanics with AIDS. Psychiatr Med. 1991; 9(3):455-67. View

11.

Freedberg K, Tosteson A, Cohen C, Cotton D . Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. J Acquir Immune Defic Syndr (1988). 1991; 4(5):521-31. View

12.

Sattler F, Cowan R, Nielsen D, Ruskin J . Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann Intern Med. 1988; 109(4):280-7. DOI: 10.7326/0003-4819-109-4-280. View